25.01.2006 16:39:00

Fisher Scientific Chairman Emeritus Frank Jellinek Jr. Dies in Plane Crash

Frank H. Jellinek Jr., chairman emeritus of FisherScientific International Inc. (NYSE: FSH), died yesterday morning in atragic plane crash at the McClellan-Palomar Airport in Carlsbad,Calif. Jellinek, 60, is survived by his wife, Judy, two children andtwo grandchildren.

"All of us at Fisher are deeply saddened by the loss of our goodfriend. Our heartfelt sympathy and prayers go out to Frank's family,"said Paul M. Montrone, chairman and chief executive officer of FisherScientific International. "Frank was a great leader and an outstandingperson who dedicated his life to his family, company and community.Everyone who knew and worked with him was impressed by his passion forthe business and his warm personality. He will be greatly missed."

Jellinek was appointed chairman emeritus following the 2004 mergerof Apogent Technologies and Fisher Scientific International. Prior tothe merger, he served as chairman and chief executive officer ofApogent Technologies.

Jellinek was a veteran in the scientific-research industry withmore than 40 years of experience. In 1962, at the age of 15, he beganworking at Erie Scientific, a microscope slide company his grandfatherfounded.

Erie Scientific was sold to Sybron Corporation in 1969 andJellinek remained with the company, eventually becoming president ofSybron in 1998. In 2000, Sybron changed its name to ApogentTechnologies, and Jellinek was named president and CEO.

Born in Buffalo, N.Y., Jellinek earned a bachelor's degree inbusiness administration from Miami University in Ohio and an MBA fromCanisius College in New York.

Fisher Scientific: A World Leader in Serving Science

Fisher Scientific International Inc. (NYSE: FSH) is a leadingprovider of products and services to the scientific community. Fisherfacilitates discovery by supplying researchers and clinicians in labsaround the world with the tools they need. We serve pharmaceutical andbiotech companies; colleges and universities; medical-researchinstitutions; hospitals; reference, quality-control, process-controland R&D labs in various industries; as well as government agencies.From biochemicals, cell-culture media and proprietary RNAi technologyto rapid-diagnostic tests, safety products and other consumablesupplies, Fisher provides more than 600,000 products and services.This broad offering, combined with Fisher's globally integrated supplychain and unmatched sales and marketing presence, helps make our350,000 customers more efficient and effective at what they do.

Founded in 1902, Fisher Scientific is a FORTUNE 500 company and isa component of the S&P 500 Index. Fisher Scientific is a companycommitted to high standards and delivering on our promises -- tocustomers, shareholders and employees alike. Additional informationabout Fisher is available on the company's Web site atwww.fisherscientific.com.

Analysen zu Thermo Fisher Scientific Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Thermo Fisher Scientific Inc 575,00 -1,59% Thermo Fisher Scientific Inc